NALDEMEDINE | NALDEMEDINE | ATC A06AH05
METABOLISM OPIOID ANTAGONIST INDICATED FOR THE TREATMENT OF OPIOID-INDUCED CONSTIPATION (OIC) IN ADULT PATIENTS WITH CHRONIC NON-CANCER PAIN DERIVATIVE OF NALTREXONE | ORAL | Tmax 0.75 HOUR VD 155 LITER PPB 93.5 PERCENT HT 11 HOUR SOLUBILITY SLIGHTLY SOLUBLE IN WATER | MU OPIOID RECEPTOR DELTA OPIOID RECEPTOR KAPPA OPIOID RECEPTOR | Mu-type opioid receptor UNIPROT P35372 OPRM1 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |